| Main Line Hospital Lankenau | |
| 100 Lancaster Ave, Wynnewood, Pennsylvania 19096 | |
| (610) 645-2000 | |
| Name | Main Line Hospital Lankenau |
|---|---|
| Type | Acute Care Hospital |
| Location | 100 Lancaster Ave, Wynnewood, Pennsylvania |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 390195 |
| NPI Number | 1033558671 |
| Organization Name | LANKENAU MEDICAL CENTER |
| Address | 100 E Lancaster Ave, Mob S Suite 422, Wynnewood, PA 19096 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 484-476-2169 |
News Archive
With modern advances in genetic engineering occurring almost every day, the latest discovery concerns antibiotic resistance. Using the powerful gene editor CRISPR, scientists reported the development of a gene-drive system that is 100 times as efficient as other current systems at inactivating a specific bacterial gene responsible for making the bacterium antibiotic-resistant and which is present as multiple copies within the same bacterial cell.
Biogen Idec today announced it has completed its purchase of Elan Corporation's interest in TYSABRI (natalizumab) and has gained full strategic, commercial and decision-making rights to TYSABRI.
To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the official grand opening of its expanded regional headquarters facility in Singapore's Science Park I.
Optical illusions can be fun to experience and debate, but understanding how human brains perceive these different phenomena remains an active area of scientific research.
Chinese officials have unveiled a health-care plan which promises to deliver to all its 1.3 billion citizens, fair and affordable health services by the year 2020.
› Verified 6 days ago
| NPI Number | 1235544156 |
| Organization Name | LANKENAU HOSPITAL |
| Address | 100 E Lancaster Ave, Wynnewood, PA 19096 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 484-476-3000 |
News Archive
With modern advances in genetic engineering occurring almost every day, the latest discovery concerns antibiotic resistance. Using the powerful gene editor CRISPR, scientists reported the development of a gene-drive system that is 100 times as efficient as other current systems at inactivating a specific bacterial gene responsible for making the bacterium antibiotic-resistant and which is present as multiple copies within the same bacterial cell.
Biogen Idec today announced it has completed its purchase of Elan Corporation's interest in TYSABRI (natalizumab) and has gained full strategic, commercial and decision-making rights to TYSABRI.
To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the official grand opening of its expanded regional headquarters facility in Singapore's Science Park I.
Optical illusions can be fun to experience and debate, but understanding how human brains perceive these different phenomena remains an active area of scientific research.
Chinese officials have unveiled a health-care plan which promises to deliver to all its 1.3 billion citizens, fair and affordable health services by the year 2020.
› Verified 6 days ago
| NPI Number | 1245335629 |
| Organization Name | MAIN LINE HOSPITALS, INC. |
| Doing Business As | LANKENAU HOSPITAL |
| Address | 100 E Lancaster Ave, Wynnewood, PA 19096 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 610-645-2000 |
News Archive
With modern advances in genetic engineering occurring almost every day, the latest discovery concerns antibiotic resistance. Using the powerful gene editor CRISPR, scientists reported the development of a gene-drive system that is 100 times as efficient as other current systems at inactivating a specific bacterial gene responsible for making the bacterium antibiotic-resistant and which is present as multiple copies within the same bacterial cell.
Biogen Idec today announced it has completed its purchase of Elan Corporation's interest in TYSABRI (natalizumab) and has gained full strategic, commercial and decision-making rights to TYSABRI.
To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the official grand opening of its expanded regional headquarters facility in Singapore's Science Park I.
Optical illusions can be fun to experience and debate, but understanding how human brains perceive these different phenomena remains an active area of scientific research.
Chinese officials have unveiled a health-care plan which promises to deliver to all its 1.3 billion citizens, fair and affordable health services by the year 2020.
› Verified 6 days ago
| NPI Number | 1336440700 |
| Organization Name | LANKENAU MEDICAL CENTER |
| Address | 100 Lancaster Ave, Suite 418 Lankenau Medical Center, Wynnewood, PA 19096 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 484-476-8464 |
News Archive
With modern advances in genetic engineering occurring almost every day, the latest discovery concerns antibiotic resistance. Using the powerful gene editor CRISPR, scientists reported the development of a gene-drive system that is 100 times as efficient as other current systems at inactivating a specific bacterial gene responsible for making the bacterium antibiotic-resistant and which is present as multiple copies within the same bacterial cell.
Biogen Idec today announced it has completed its purchase of Elan Corporation's interest in TYSABRI (natalizumab) and has gained full strategic, commercial and decision-making rights to TYSABRI.
To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the official grand opening of its expanded regional headquarters facility in Singapore's Science Park I.
Optical illusions can be fun to experience and debate, but understanding how human brains perceive these different phenomena remains an active area of scientific research.
Chinese officials have unveiled a health-care plan which promises to deliver to all its 1.3 billion citizens, fair and affordable health services by the year 2020.
› Verified 6 days ago
| NPI Number | 1558674911 |
| Organization Name | MAIN LINE HOSPITALS, INC. |
| Address | 100 E Lancaster Ave, Wynnewood, PA 19096 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 484-476-2000 |
News Archive
With modern advances in genetic engineering occurring almost every day, the latest discovery concerns antibiotic resistance. Using the powerful gene editor CRISPR, scientists reported the development of a gene-drive system that is 100 times as efficient as other current systems at inactivating a specific bacterial gene responsible for making the bacterium antibiotic-resistant and which is present as multiple copies within the same bacterial cell.
Biogen Idec today announced it has completed its purchase of Elan Corporation's interest in TYSABRI (natalizumab) and has gained full strategic, commercial and decision-making rights to TYSABRI.
To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the official grand opening of its expanded regional headquarters facility in Singapore's Science Park I.
Optical illusions can be fun to experience and debate, but understanding how human brains perceive these different phenomena remains an active area of scientific research.
Chinese officials have unveiled a health-care plan which promises to deliver to all its 1.3 billion citizens, fair and affordable health services by the year 2020.
› Verified 6 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
With modern advances in genetic engineering occurring almost every day, the latest discovery concerns antibiotic resistance. Using the powerful gene editor CRISPR, scientists reported the development of a gene-drive system that is 100 times as efficient as other current systems at inactivating a specific bacterial gene responsible for making the bacterium antibiotic-resistant and which is present as multiple copies within the same bacterial cell.
Biogen Idec today announced it has completed its purchase of Elan Corporation's interest in TYSABRI (natalizumab) and has gained full strategic, commercial and decision-making rights to TYSABRI.
To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the official grand opening of its expanded regional headquarters facility in Singapore's Science Park I.
Optical illusions can be fun to experience and debate, but understanding how human brains perceive these different phenomena remains an active area of scientific research.
Chinese officials have unveiled a health-care plan which promises to deliver to all its 1.3 billion citizens, fair and affordable health services by the year 2020.
› Verified 6 days ago
Main Line Hospital Lankenau Acute Care Hospital Location: 100 Lancaster Ave, Wynnewood, Pennsylvania 19096 Phone: (610) 645-2000 |